Status:
COMPLETED
Substance Use Treatment and Recovery Team (START)
Lead Sponsor:
RAND
Collaborating Sponsors:
Cedars-Sinai Medical Center
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-use Disorder
Opioid-Related Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Despite high prevalence, few hospitalized inpatients with opioid or alcohol use disorders (OAUDs) receive evidence-based treatments while in the hospital or get linked with appropriate follow-up care,...
Detailed Description
The specific aims of this three-year R34 are to prepare for a clinical trial by (1) developing the protocol and resources for Substance Use Treatment and Recovery Team (START) to address untreated opi...
Eligibility Criteria
Inclusion
- Inpatient at CSMC
- Age 18 and older
- Screens positive for moderate to severe OAUDs based on the alcohol and opioid questions on the
- World Health Organization (WHO) Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST).
- Speaks English as primary language
- The usual attending physician agrees to patient's participation
- Has decision-making capacity and is not gravely disabled
Exclusion
- Currently receiving FDA-approved medication treatment for an opioid or alcohol use disorder
- Gravely disabled (per clinical judgement)
- Does not have decision-making capacity (per clinical judgement)
Key Trial Info
Start Date :
December 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04314648
Start Date
December 4 2020
End Date
December 31 2022
Last Update
April 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048